QUOIN PHARMACEUTICALS LT-ADR (QNRX) Forecast, Price Target & Analyst Ratings

NASDAQ:QNRX • US74907L4095

Current stock price

6.25 USD
-0.21 (-3.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QUOIN PHARMACEUTICALS LT-ADR (QNRX).

Forecast Snapshot

Consensus Price Target

Price Target
$30.26
+ 384.16% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.03
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$30.26
Upside
+ 384.16%
From current price of $6.25 to mean target of $30.26, Based on 8 analyst forecasts
Low
$14.14
Median
$35.70
High
$42.00

Price Target Revisions

1 Month
-28.80%
3 Months
-28.80%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for QNRX. The average price target is 30.26 USD. This implies a price increase of 384.16% is expected in the next year compared to the current price of 6.25.
The average price target has been revised downward by 28.8% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

QNRX Current Analyst RatingQNRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

QNRX Historical Analyst RatingsQNRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
QNRX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about QNRX.
In the previous month the buy percentage consensus was at a similar level.
QNRX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-03-15Maxim GroupMaintains Buy -> Buy
2022-09-07Alliance Global PartnersInitiate Buy
2022-05-06Ladenburg ThalmannInitiate Buy
2022-01-07Maxim GroupInitiate Buy
2021-12-15JMP SecuritiesInitiate Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$2.03
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
68.77%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

QNRX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -2.03 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2031

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
QNRX revenue by date.QNRX revenue by date.
N/AN/AN/AN/AN/AN/AN/A
201.86%		N/A
59.08%		N/A
28.14%
EBITDA
YoY % growth
QNRX ebitda by date.QNRX ebitda by date.
N/AN/A-8.014M-6.045M
24.58%		-3.861M
36.12%		-5.959M
-54.33%		-9.154M
-53.61%		-9.275M
-1.32%		-9.429M
-1.66%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
QNRX ebit by date.QNRX ebit by date.
N/AN/A
-57.89%		-8.142M
-17.49%		-6.271M
22.98%		-4.07M
35.09%		-6.063M
-48.95%		-9.258M
-52.69%		-9.379M
-1.30%		-9.529M
-1.60%		N/A
-70.93%		N/A
-30.19%		N/A
93.50%		N/A
3,151.19%		N/A
37.78%		N/A
81.67%		N/A
33.86%
Operating Margin
QNRX operating margin by date.QNRX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
QNRX eps by date.QNRX eps by date.
N/AN/A
-64.36%		N/AN/AN/AN/A-2,977.80
88.57%		-358.40
87.96%		-81.20
77.34%		-20.99
74.15%		N/A
75.36%		N/A
2.17%		N/A
48.39%		N/A
1,866.80%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-2.03
68.77%		-1.66
73.61%		-1.10
83.66%		-1.12
25.20%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-4.425M
-11.82%		-4.573M
-20.55%		-4.834M
-20.25%		-4.984M
-17.62%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

QNRX Yearly Revenue VS EstimatesQNRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 50M 100M 150M
QNRX Yearly EPS VS EstimatesQNRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -50K -100K -150K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.32%
EPS Next 5 Year
43.14%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

QUOIN PHARMACEUTICALS LT-ADR / QNRX Forecast FAQ

What is the average price target for QUOIN PHARMACEUTICALS LT-ADR (QNRX) stock?

8 analysts have analysed QNRX and the average price target is 30.26 USD. This implies a price increase of 384.16% is expected in the next year compared to the current price of 6.25.

Can you provide the upcoming earnings date for QUOIN PHARMACEUTICALS LT-ADR?

QUOIN PHARMACEUTICALS LT-ADR (QNRX) will report earnings on 2026-05-11.

What are the consensus estimates for QNRX stock next earnings?

The consensus EPS estimate for the next earnings of QUOIN PHARMACEUTICALS LT-ADR (QNRX) is -2.03 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for QNRX stock?

The number of analysts covering QUOIN PHARMACEUTICALS LT-ADR (QNRX) is 8.